Document:

AMENDMENT NO. 2 TO RIGHTS AGREEMENT

AMENDMENT NO. 2 TO RIGHTS AGREEMENT

      AMENDMENT NO. 2 TO RIGHTS AGREEMENT
(this “Amendment”) is made as of May 5, 2000 by and among COVENTRY
HEALTH CARE, INC., a Delaware corporation (the “Company”), and
CHASEMELLON SHAREHOLDER SERVICES, LLC (the “Rights Agent”). Reference
is made herein to that certain Rights Agreement, dated as of March 30, 1998, by
and among COVENTRY HEALTH CARE, INC., a Delaware corporation, and CHASEMELLON
SHAREHOLDER SERVICES, LLC, as amended by Amendment No. 1 to Rights Agreement
dated as of December 18, 1998 (as amended, the “Rights Agreement”).
Capitalized terms not herein defined shall have the meanings ascribed thereto in
the Rights Agreement.  

   RECITALS

     WHEREAS, Warburg, Pincus Equity Partners, L.P., a Delaware limited partnership, Warburg, Pincus Netherlands Equity Partners
I, C.V., a Netherlands limited partnership, Warburg, Pincus Netherlands Equity Partners II, C.V., a Netherlands limited partnership,
and Warburg, Pincus Netherlands Equity Partners III, C.V., a Netherlands limited partnership (collectively, the “Warburg Entities”),
Principal Health Care Inc., an Iowa corporation intend to enter into the Purchase Agreement of even date herewith pursuant to which
the Warburg Entities have agreed to acquire 10,000,000 shares of the Company's Common Stock (the “Purchase Agreement”);

     WHEREAS, pursuant to Section 27 of the Rights Agreement, the Rights Agreement may be amended by the parties hereto;

     NOW, THEREFORE, in consideration
of the premises and the mutual covenants and agreement herein contained, and
intending to be legally bound hereby, the parties hereto agree as follows: 

     1.  Amendment of Section 1(a).  Section 1(a) of the Rights Agreement is hereby amended and restated in its entirety as follows:

     (a) “Acquiring Person” means any Person which (or which together with all its
Affiliates and Associates) shall be the Beneficial Owner of 15% or more of the shares of Common Stock then outstanding. Notwithstanding the foregoing, (x) the
term “Acquiring Person” shall not include the Company, any Subsidiary of the Company, any employee benefit plan maintained by the Company or any of
its Subsidiaries, or any trustee or fiduciary with respect to such plan acting in such capacity; and (y) no Person shall become an “Acquiring Person”
as the result of (A) the acquisition of Common Stock (or other securities convertible into shares of Common Stock or other rights with respect to Common
Stock) directly from the Company, or (B) an acquisition of Common Stock by the Company which, by reducing the number of shares outstanding, increases the
proportionate number of shares Beneficially Owned by such Person (alone or
together with all Affiliates and Associates) to 15% or more of the Shares of
Common Stock then outstanding; provided, however, that if a Person
(together with its Affiliates or Associates) becomes the Beneficial Owner of 15%
or more of the Common Stock then outstanding by reason of share purchases by the
Company, and such Person (or an Affiliate or Associate) subsequently becomes the
Beneficial Owner of any additional Common Stock, then such Person shall be
deemed to be an “Acquiring Person.” Notwithstanding the foregoing, if
the Board of Directors of the Company determines in good faith that a Person who
would otherwise be an “Acquiring Person,” as defined pursuant to the
foregoing provisions of this paragraph (a) has become such inadvertently, and
such Person divests as promptly as practicable a sufficient number of shares of
Common Stock so that such Person would no longer be an “Acquiring
Person” as defined pursuant to the foregoing provisions of this paragraph
(a), then any such Person shall not be deemed to be an “Acquiring
Person” for purposes of this Agreement. Notwithstanding anything to the
contrary in this Agreement: 

     (i) None of Warburg, Pincus Ventures, L.P., a Delaware limited  partnership, Warburg, Pincus Equity  Partners,  L.P., a
Delaware limited partnership, Warburg, Pincus Netherlands Equity Partners I, C.V., a Netherlands limited partnership,  Warburg, Pincus
Netherlands Equity Partners II, C.V., a Netherlands  limited  partnership, Warburg, Pincus Netherlands Equity Partners III, C.V., a
Netherlands limited  partnership (collectively, “Warburg”) and any Affiliate or Associate of Warburg shall be deemed an “Acquiring
Person” hereunder for so long as none of Warburg and any Affiliate or Associate  thereof shall have breached,  in any material respect,
any provision of Sections 1(a) or 2 of that certain Shareholder's Agreement dated as of May 5, 2000 by and among Warburg and the
Company (the “Warburg Shareholders Agreement”) and, after the Warburg Shareholders Agreement shall no longer be effective,  until such
time as Warburg and any of its Affiliates and Associates shall Beneficially Own less than 15% of the Common Stock.

     (ii) None of Principal Mutual Life Insurance Company, an Iowa corporation now known as Principal Life Insurance
Company (“Mutual”) and any Affiliate or Associate of Mutual shall be deemed an “Acquiring Person” hereunder for so long as none of Mutual
and any Affiliate or Associate thereof shall have breached, in any material respect, any provision of Sections 1(a) or 4 of that certain Shareholder’s
Agreement dated as of April 1, 1998 by and among Mutual, Principal Health Care, Inc. and the Company (the “Shareholders Agreement”) and, after the
Shareholders Agreement shall no longer be effective, until such time as Mutual and any of its Affiliates and Associates shall Beneficially Own less than 15% of
the Common Stock.

     2.   Rights Agreement Otherwise Unamended.  The terms of the Rights  Agreement not amended  hereby shall,  except as the context
unambiguously requires, remain in full force and effect.

     3.    Rights Agreement Otherwise
Unamended. This Amendment, together with the provisions of the Rights
Agreement not amended hereby, constitute the entire agreement between the
parties hereto with respect to the subject matter hereof and supersede all other
prior agreements, whether written or oral, between the parties hereto.

     4.   Counterparts.This Amendment may be executed in one or more counterparts, each of which shall be deemed an original and all
of which together shall constitute one and the same document.

     IN WITNESS WHEREOF, each of the
parties hereto has caused this Amendment to be executed in its respective
corporate name by one of its duly authorized officers, all as of the date first
above written. 

	COVENTRY HEALTH CARE, INC.
	By: /s/ Allen F. Wise
	Name:   Allen F. Wise
	Title:   President and Chief Executive Officer
	
	CHASEMELLON SHAREHOLDER SERVICES, LLC
	By: /s/ Rita A. Swartz
	Name:   Rita A. Swartz
	Title:   Vice PresidentAllen Wise Employment Agreement

EMPLOYMENT AGREEMENT

             This  Agreement is made the 18th of  December,  2000,  effective  as of January 1, 2001,  by and
between Coventry Health Care, Inc., a Delaware  corporation (the "Company"),  and Allen F. Wise (the
"Executive").

          WHEREAS, the Company employs the
Executive as its President and Chief Executive Officer pursuant to an Employment
Agreement dated December 30, 1998, and the parties desire to amend the terms of
such employment as set forth herein. 

          NOW, THEREFORE, in consideration
of the mutual covenants contained in this Employment Agreement, the parties
hereby agree as follows: 

                               1.    TERM AND DUTIES

          1.1    The term of this Agreement
commenced as of January 1, 1999, and shall continue through December 31, 2003
and will continue on a year-to-year basis thereafter in the absence of notice of
either party given no later than the September 30 prior to the expiration, or
unless otherwise extended (the “Term”). 

          1.2    Executive shall serve as
President and Chief Executive Officer, shall report to the Board of Directors
and shall be responsible for the overall direction, administration and
leadership of the Company, including, but not limited to, the establishment and
implementation of policies and directives, formulation of long range plans,
goals and objectives, effective management of employees, and such other powers
and duties normally associated with such position or as may be delegated or
assigned to the Executive by the Company’s Board of Directors. During the
term of the Agreement, the Executive shall also serve without additional
compensation in such other offices of the Company or its subsidiaries or
affiliates to which he may be elected or appointed by the Board of Directors of
the Company or its subsidiaries or affiliates, respectively. 

                          2.   COMPENSATION AND BENEFITS

          2.1    The Company shall pay the
Executive a base salary (“Base Salary”) of not less than $700,000 per
annum, subject to applicable withholdings. The Base Salary shall be payable in
equal semi-monthly payments according to the customary payroll practices of the
Company. The Base Salary shall be reviewed annually and shall be subject to
increase by the Board of Directors (or the Compensation and Benefits Committee
of the Board (“Committee”)) from time to time. 

          2.2    The Executive shall be
eligible for an annual bonus (“Bonus”). The Executive’s bonus and
performance factors shall be determined on an annual basis by the Committee at
their sole discretion and may range from 0 to 200% of Base Salary. 

          2.3    The terms and conditions of
all stock options and restricted share awards previously granted to Executive
shall remain in full force and effect. 

          2.4    The Executive will be entitled
to participate in all employee benefit plans or programs and receive all
benefits and perquisites to which any salaried employee is eligible under any
existing or future plan or program for salaried employees, including, without
limitation, all plans developed for executive officers of the Company. These
plans or programs may include group hospitalization, health care, dental care,
life or other insurance, tax qualified pension, savings, thrift and profit
sharing plans, termination pay programs, sick leave plans, travel or accident
insurance, disability insurance, and contingent compensation plans, including
capital accumulation programs, restricted stock programs, stock purchase
programs and stock option plans. Nothing in this Agreement will preclude the
Company from amending or terminating any of the plans or programs applicable to
salaried employees or executive officers. 

          2.5   The Company will reimburse the
Executive for all reasonable travel and other expenses incurred by the Executive
in connection with the performance of his duties upon proper documentation in
accordance with Company policies. In addition, in lieu of charging any auto
mileage for business use, the Executive will be provided a leased automobile,
and all reasonable operating costs, including insurance, gas, maintenance, and
repairs, will be paid by the Company. To the degree that the Executive is
accountable for any income taxes arising from this Section, he will have sole
responsibility for calculating and paying such taxes. 

          2.6    The Executive will be entitled
to 50 hours annual personal use of the Company plane and full reimbursement of
the associated additional income tax liability. 

                      3.   DEATH AND DISABILITY COMPENSATION

          3.1    In the event of the death of
the Executive during the Term, payments under this Employment Agreement shall
cease as of the date of death, except for the following benefits to be paid to
the Executive’s beneficiaries: 

               (a) any earned but unpaid base
salary and a lump sum payment equal to the average annual bonus compensation for
the two (2) calendar years immediately preceding the death of Executive,
prorated for the year death occurs; 

               (b) for thirty-six (36) months
following the date of the Executive’s death, the Company shall reimburse
the Executive’s designated beneficiary for the cost of the designated
beneficiary’s medical and dental insurance as in effect at the date of the
Executive’s death; 

               (c) the  exercisability  of stock  options  granted to the  Executive  shall be  governed by any
applicable stock option agreements and the terms of the respective stock option plans; and

               (d) the Executive’s
designated beneficiary will be entitled to receive the proceeds of any life or
other insurance or other death benefit programs provided or referred to in this
Employment Agreement. 

          3.2    Notwithstanding the disability
of the Executive, the Company will continue to pay the Executive pursuant to
Section 2 hereof during the Term, unless the Executive’s employment is
earlier terminated in accordance with this Agreement. In the event the
disability continues for a period of three (3) months, the Company may
thereafter terminate this Agreement and the Executive’s employment.
Following such termination, the Company will pay the Executive amounts equal to
the following: 

                          (a)     his regular installments of Base Salary, as of the time of termination,  for a period not to
exceed the commencement of payments under any Company provided long-term disability plan;

               (b) a lump sum payment equal to
the average annual bonus compensation for the two (2) calendar years immediately
preceding the year of termination due to disability, prorated for the year the
disability occurs; 

               (c) for thirty-six (36) months
following the date of the Executive’s termination due to disability, the
Company shall reimburse the Executive for the cost of the Executive’s
medical and dental insurance as in effect at the date of the Executive’s
termination; and 

               (d) if the Executive is receiving
disability benefits under the Company’s qualified long-term disability
program, the Executive will receive a monthly payment equal to 60% multiplied by
pre-disability earnings (as defined by the qualified long-term disability plan)
less any monthly benefit paid under the qualified long-term disability program.
Such payments shall continue to cessation of payments under the Company’s
qualified long-term disability program. 

               (e) the exercisability of stock
options granted to the Executive shall be governed by any applicable stock
option agreements and the terms of the respective stock option plans. 

          3.3    During the period the
Executive is receiving payments following his disability and as long as he is
physically and mentally able to do so, the Executive will furnish information
and assistance to the Company and from time to time will make himself available
to the Company to undertake assignments consistent with his position or prior
position with the Company and his physical and mental health. If the Company
fails to make a payment or provide a benefit required as part of this Employment
Agreement, the Executive’s obligation to provide information and assistance
will cease. 

          3.4    For purposes of this
Agreement, the term “disability” will have the same meaning as is
attributed to such term, or any substantially similar term, in the
Company’s long-term disability income plan as in effect from time to time.
The Company’s group long-term disability policy in existence at the time of
disability shall be considered to be a part of this Agreement. 

                          4.   TERMINATION OF EMPLOYMENT

          4.1    Except in the case of the two
year period following a Change in Control (as hereinafter defined), if the
Executive suffers a Termination Without Cause (hereinafter defined) or a
Constructive Termination (as hereinafter defined), the Company will continue to
pay the Executive the following: 

               (a) for a period of twenty-four
(24) months after Termination Without Cause or Constructive Termination, a
monthly amount equal to 250% of the sum of the Executive’s combined (i)
Base Salary as in effect at the time of the termination and (ii) the average
Bonus for the two (2) calendar years immediately preceding the year of
termination, divided by twenty-four (24); and 

               (b) for thirty (30) months
following such Termination Without Cause or Constructive Termination, the
Company shall reimburse the Executive for the cost of the Executive’s
medical and dental insurance as in effect at the date of termination. In
addition, the Executive will receive twelve (12) months additional vesting
credit for all stock options and restricted stock awards and the Company will
purchase and transfer unrestricted title to the automobile referred to in
Section 2.5 to Executive. 

          4.2    If the Executive suffers a
Termination Without Cause or Constructive Termination within two (2) years
following a Change in Control, the Company will pay to the Executive the
following: 

               (a) in a lump sum upon such
termination an amount equal to the sum of (i) 300% of the Executive’s
combined (A) Base Salary as in effect at the time of the termination and (B)
average Incentive Bonus for the two (2) calendar years immediately preceding the
year of termination, and (ii) to the extent that such foregoing amount or any
other payment in the nature of compensation (within the meaning of Section 280G
of the Internal Revenue Code of 1986, as amended, and the regulations
promulgated thereunder (“Section 280G”)) to or for the benefit to the
Executive (or any part of such amount or other payment) constitutes an
“excess parachute payment” within the meaning of Section 280G, the
amount, if any, of (A) such “excess parachute payment” multiplied by a
fraction, the numerator of which is the number one (1.00) and the denominator of
which is (I) the number (1.00) minus (II) the effective tax rate under Section
280G applicable to the Executive expressed as decimal, minus (B) the amount of
such “excess parachute payment”; 

               (b) for thirty-six (36) months
following such Termination Without Cause or Constructive Termination following a
Change of Control, the Company shall reimburse the Executive for the cost of the
Executive’s medical and dental insurance as in effect at the date of
termination; 

               (c) the Company will purchase and transfer  unrestricted title to
the automobile  referred to in Section 2.5 to Executive; and

               (d) all stock options and all restricted  stock granted to the Executive shall vest in full upon
a Change of Control.

          4.3    If the Executive suffers a
Termination with Cause or the Executive terminates his employment with the
Company not due to a Constructive Termination, death or disability (as defined
in Section 3.4) (a “Voluntary Termination”), then the Company will not
be obligated to pay the Executive any amounts of compensation or benefits
following the date of termination, except earned but unpaid Base Salary through
the date of termination, which will be paid in a lump sum. The exercisability of
stock options granted to the Executive shall be governed by any applicable stock
option agreements and plans. 

             4.4   For purposes of this
Employment Agreement, the following terms have the following meanings:

               (a) A “Change in
Control” shall occur if at any time, substantially all of the assets of the
Company are sold or transferred by sale, merger or otherwise, to an entity which
is not a direct or indirect subsidiary of the Company or if any
“person” (as such term is used in Sections 13(d) or 14 (d) of the
Securities Exchange Act of 1934, as amended) is or becomes the beneficial owner,
directly or indirectly, of securities of the Company representing 50% or more of
the combined voting power of the then existing outstanding securities of the
Company. 

               (b) “Constructive
Termination” means termination by the Executive which follows (a) a
reassignment of duties, responsibilities, title, or reporting relationships
(including being required to report to anyone other than the ultimate
controlling entity’s board of directors after a Change in Control) that are
not at least the equivalent of his then current position as set forth in Section
1.2 or the compensation and benefits provided herein, (b) the intentional or
material breach by the Company of this Agreement, (c) the continuous and
material involvement of the Board in the management of the Company, on a level
not warranted by exceptional circumstances, that is clearly greater than that
previously exercised by the Board or (d) reassignment, after a Change in
Control, to a geographic location more than fifty miles from Bethesda, Maryland.
The Executive shall have a period of ninety (90) days after termination of his
employment to assert against the Company that he suffered a Constructive
Termination, and after the expiration of such ninety (90) day period, the
Executive shall be deemed to have irrevocably waived the right to such
assertion. 

               (c) “Termination With
Cause” means termination by the Company, acting in good faith, by written
notice to the Executive specifying the event relied upon for such termination,
due to the Executive’s conviction for a felony, the Executive’s
intentional perpetration of a fraud, embezzlement or other act of dishonesty or
the Executive’s intentional breach of a trust or fiduciary duty which
materially adversely affects the Company or its shareholders. 

               (d) “Termination Without
Cause” means termination by the Company other than due to the
Executive’s death or disability or Termination With Cause. 

                        5.   OTHER DUTIES OF THE EXECUTIVE

          5.1    The Executive shall devote
substantially all of his working time to the business of the Company and during
the Term shall not take, directly or indirectly, an active role in any other
business without the prior written consent of the Company; but except as
provided in Section 5.3, this Section shall not prevent the Executive from
serving as a director of other entities not affiliated with the Company, from
making real estate or other investments of a passive nature or from
participating in the activities of a charitable organization where such
participation does not adversely affect the Executive’s ability to perform
his duties under this Agreement. 

          5.2    The Executive will, upon
reasonable notice, during or after the Term of this Employment Agreement,
furnish information as may be in his possession and cooperate with the Company
as may reasonably be requested in connection with any claims or legal actions in
which the Company is or may become a party. The Executive shall receive
reasonable compensation for the time expended by him pursuant to this Section
5.2 after the Term. 

          5.3    The Executive acknowledges
that certain information pertaining to the business and operations of the
Company such as strategic plans, product development, financial costs, pricing
terms, sales data or new or developing business opportunities
(“Confidential Information”), is confidential and is a unique and
valuable asset of the Company. Access to and knowledge of this Confidential
Information are essential to the performance of the Executive’s duties
under this Agreement. The Executive will not during the term of this Agreement
or following termination of his employment except to the extent reasonably
necessary in the performance of his duties under this Agreement, give to any
person, firm, association, corporation or governmental agency any Confidential
Information except as required by law. The Executive will not make use of this
Confidential Information for his own purposes or for the benefit of any person
or organization other than the Company. The Executive will also use his best
efforts to prevent the disclosure of this Confidential Information by others.
All records, memoranda, etc. relating to the business of the Company whether
made by the Executive or otherwise coming into his possession will remain the
property of the Company. 

          5.4    The Executive will not Compete
with the Company (as hereinafter defined) at any time while he is employed by
the Company. Except after a Change in Control or after non-renewal under Section
1.1, in the event of a Termination Without Cause or Constructive Termination
pursuant to Section 4.1, the Executive will not Compete with the Company for a
period of two (2) years from the date of such termination. In the event of a
termination after a Change in Control that gives rise to payments to Executive
under Section 4.2, Executive will not Compete with the Company for one (1) year
from the date of termination. In the event of a Voluntary Termination in which
the Executive only receives payment as defined under Section 4.3, or which
follows a Company non-extension notice under Section 1.1, there will be no
restriction on the Executive’s right to Compete with the Company after the
date his employment terminates. For the purposes of this Section 5.4, the term
“Compete with the Company” means action by the Executive, direct or
indirect, either as an officer, director, stockholder, owner, partner, employee
or in any other capacity, resulting in the Executive having any legal or
equitable ownership or other financial or non-financial interest in or
employment with, any HMO, managed care or health insurance business within a
fifty mile radius of any location where the Company or any subsidiary or
affiliate of the Company conducts such business at the date of a termination of
the Executive’s employment; provided, however, that the term “Compete
with the Company” shall not include ownership (without any more extensive
relationship) of a less than a five percent (5%) interest in any publicly-held
corporation or other business entity. The Executive acknowledges that the
covenants contained herein are reasonable as to geographic and temporal scope.
The Executive acknowledges that his breach or threatened or attempted breach of
any provision of Section 5.4 may cause irreparable harm to the Company not
compensable in monetary damages and that the Company may be entitled, in
addition to all other applicable remedies, to a temporary and permanent
injunction and a decree for specific performance of the terms of Section 5.4. 

                        6.   INDEMNIFICATION OF EXECUTIVE

          6.1    The Company shall indemnify
the Executive and shall reimburse the Executive’s expenses under the
circumstances described, and to the maximum extent provided under the mandatory
and the permissive indemnification and expense reimbursement provisions of
Delaware law. The provisions of this Section 6.1 shall continue in full force
and effect after Executive ceases to serve as an officer, director, employee or
in any other capacity with the Company or any of its affiliates, and shall inure
to the benefit of his heirs, executors or administrators. 

                                7.   MISCELLANEOUS

          7.1    This Agreement contains the
entire understanding between the Company and the Executive with respect to the
subject matter and supersedes any prior employment or severance agreements
between the Company and its affiliates, and the Executive. 

          7.2    This Agreement may not be
modified or amended except in writing signed by the parties. No term or
condition of this Employment Agreement will be deemed to have been waived except
in writing by the party charged with waiver. A waiver shall operate only as to
specific term or condition waived and will not constitute a waiver for the
future or act on anything other than that which is specifically waived. 

          7.3    Should any part of this
Agreement be declared invalid for any reason, such invalidity shall not affect
the validity of any remaining portion hereof and such remaining portion shall
continue in full force and effect as if this Employment Agreement had been
originally executed without including the invalid part. Should any covenant of
this Employment Agreement be unenforceable because of its geographic scope or
term, its geographic scope or tem shall be modified to such extent as may be
necessary to render such convenant enforceable. 

          7.4    Titles and captions in no way
define, limit, extend or describe the scope of this Agreement nor the intent of
any provision thereof. 

          7.5    This Agreement may be executed
in any number of counterparts, each of which shall be deemed an original, but
all of which together shall constitute one and the same instrument. 

          7.6    This Employment Agreement has
been made in the State of Maryland and its interpretation, and enforcement shall
be governed by the laws of that state. Any dispute among the parties shall be
settled by arbitration in Bethesda, Maryland, in accordance with the rules then
obtaining of the American Arbitration Association and judgment upon the award
rendered may be entered in any court having jurisdiction thereof. All provision
hereof are for the protection and are intended to be for the benefit of the
parties hereto and enforceable directly by the binding upon each party. Each
party hereto agrees that the remedy at law of the other for any actual or
threatened breach of this Employment Agreement would be inadequate and that the
other party shall be entitled to specific performance hereof or injunctive
relief or both, by temporary or permanent injunction or such other appropriate
judicial remedy, orders as may be decided by a court of competent jurisdiction
in addition to any damages which the complaining party may be legally entitled
to recover. 

          7.7    All notices, requests,
consents and other communications hereunder shall be in writing and shall be
deemed to have been made when delivered or mailed first-class postage prepaid by
registered mail, return receipt requested, or when delivered if by hand,
overnight delivery service or confirmed facsimile transmission to the following: 

          (i)    If to the
Company,  at 6705 Rockledge Drive,  Suite 900, Bethesda,  Maryland,  20817,
Attention:  Chairman  of the  Compensation  Committee,  or at such  other  address  as may have been
furnished to the Executive by the Company in writing; or

               (ii) If to
the Executive, at 6705 Rockledge Drive, Suite 900, Bethesda, Maryland, 20817
 or ____________________________________________________ or such other address as
may have been furnished to the Company by the Executive in writing. 

             7.8   This Employment
Agreement shall be binding on the parties' successors, heirs and assigns.

          IN WITNESS WHEREOF, the
undersigned have executed this Employment Agreement as of the date first above
written. 

	COVENTRY HEALTH CARE, INC.	EXECUTIVE:
	By: /s/ John H. Austin	/s/ Allen F. Wise
	
	

	John H. Austin, Chairman	Allen F. Wise, CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00022-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00022-of-00352.parquet"}]]